(18) Jacobsen v. Islamic Republic of Iran, Civil 
Action No. 02–1365 (JR) (D.D.C. 2006). 
(19) Kerr v. Islamic Republic of Iran, 245 F. 
Supp. 2d 59 (D.D.C. 2003). 
(20) Levin v. Islamic Republic of Iran, Civil Ac-
tion No. 05–02494 (GK), 2007 WL 4564399 
(D.D.C. 2008). 
(21) Nikbin v. Islamic Republic of Iran, 517 F. 
Supp. 2d 416 (D.D.C. 2007). 
(22) Peterson v. Islamic Republic of Iran, 515 
F. Supp. 2d 25 (D.D.C. 2007). 
(23) Prevatt v. Islamic Republic of Iran, 421 F. 
Supp. 2d 152 (D.D.C. 2006). 
(24) Rafii v. Islamic Republic of Iran, Civil Ac-
tion No. 01–850 (CKK) (D.D.C. 2002). 
(25) Regier v. Islamic Republic of Iran, 281 F. 
Supp. 2d 87 (D.D.C. 2003). 
(26) Salazar v. Islamic Republic of Iran, 370 F. 
Supp. 2d 105 (D.D.C. 2005). 
(27) Sisso v. Islamic Republic of Iran, 2007 
WL 2007582 (D.D.C. 2007). 
(28) Steen v. Islamic Republic of Iran, 2003 
WL 21672820 (D.D.C. 2003). 
(29) Stern v. Islamic Republic of Iran, 271 F. 
Supp. 2d 286 (D.D.C. 2003). 
VerDate Nov 24 2008 
02:24 Feb 28, 2009
Jkt 079200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
wwoods2 on PRODPC68 with BILLS
(30) Surette v. Islamic Republic of Iran, 231 F. 
Supp. 2d 260 (D.D.C. 2002). 
(31) Tracy v. Islamic Republic of Iran, 2003 
U.S. Dist. LEXIS 15844 (D.D.C. 2003). 
(32) Turner v. Islamic Republic of Iran, 2002 
U.S. Dist. LEXIS 26730 (D.D.C. 2002). 
(33) Valore v. Islamic Republic of Iran, 478 F. 
Supp. 2d 101 (D.D.C. 2007). 
(34) Weir v. Islamic Republic of Iran, Civil Ac-
tion No. 01–1303 (TPJ) (D.D.C. 2003). 
(35) Welch v. Islamic Republic of Iran, Civil 
Action No. A01–863(CKK)(AK) (D.D.C. 2007). 
SEC. 506. RULE OF CONSTRUCTION. 
No plaintiff or class member referred to in section 
503, as a result of belonging to more than one claim iden-
tified in section 505, shall be eligible for multiple com-
pensation under section 504. 
VerDate Nov 24 2008 
02:24 Feb 28, 2009
Jkt 079200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
wwoods2 on PRODPC68 with BILLS
TITLE VI—ADDITIONAL PROVI-
SIONS RELATED TO IRANIAN 
UNCONVENTIONAL WEAPONS 
PROGRAMS 
AND 
SUPPORT 
FOR 
INTERNATIONAL 
TER-
RORISM 
SEC. 601. BIOLOGICAL WEAPONS CAPABILITIES AND PRO-
GRAMS. 
(a) STATEMENT OF POLICY.—It shall be the policy 
of the United States— 
(1) to recognize the grave threat to the United 
States and to United States allies and interests that 
Iranian biological weapons programs represent; 
(2) to use voice, vote, and influence of the 
United States within international organizations to 
raise and investigate Iranian compliance with its ob-
ligations under the Convention on the Prohibition of 
the Development, Production and Stockpiling of 
Bacteriological (Biological) and Toxin Weapons and 
on Their Destruction; and 
(3) to refrain from directly engaging with any 
person, agent, instrumentality, or official of, is affili-
ated with, or is serving as a representative of the 
Government of Iran until Iran verifiably dismantles 
VerDate Nov 24 2008 
02:24 Feb 28, 2009
Jkt 079200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
wwoods2 on PRODPC68 with BILLS
or otherwise ceases its programs conducive to pro-
ducing biological weapons. 
(b) REPORT.— 
(1) REQUIREMENT.—Not later than 180 days 
after the date of the enactment of this Act and an-
nually thereafter, the President shall transmits to 
the appropriate congressional committees an inter- 
agency assessment of Iran’s biological weapons capa-
bilities. 
(2) CLASSIFIED ANNEX.—The report required 
under paragraph (1) shall be in unclassified form to 
the greatest extent possible, but may include a clas-
sified annex where necessary. 
(3) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES DEFINED.—In this subsection, the term ‘‘ap-
propriate congressional committees’’ means the 
Committee on Foreign Affairs of the House of Rep-
resentatives and the Committee on Foreign Rela-
tions of the Senate. 
SEC. 602. IRANIAN CHEMICAL WEAPONS CAPABILITIES AND 
PROGRAMS. 
(a) STATEMENT OF POLICY.—It shall be the policy 
of the United States to— 
(1) to recognize the grave threat to the United 
States, United States allies, and United States inter-
VerDate Nov 24 2008 
02:24 Feb 28, 2009
Jkt 079200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
wwoods2 on PRODPC68 with BILLS
ests that Iranian chemical weapons programs rep-
resent; 
(2) to use voice, vote, and influence of the 
United States within international organizations to 
declare the Government of Iran in violation of its ob-
ligations under the Chemical Weapons Convention; 
and 
(3) to refrain from directly engaging with any 
person, agent, instrumentality, or official of, is affili-
ated with, or is serving as a representative of the 
Government of Iran until Iran verifiably dismantles 
otherwise ceases its programs conducive to pro-
ducing chemical weapons. 
(b) REPORT.— 
(1) IN GENERAL.—Not later 180 days after the 
date of the enactment of this Act and annually 
thereafter, the President shall transmit to the appro-
priate congressional committees an interagency as-
sessment of Iran’s chemical weapons capabilities. 
(2) CLASSIFIED ANNEX.—The report required 
under paragraph (1) shall be in unclassified form to 
the greatest extent practicable, but may include a 
classified annex if necessary. 
(3) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES DEFINED.—In this subsection, the term ‘‘ap-
VerDate Nov 24 2008 
02:24 Feb 28, 2009
Jkt 079200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
wwoods2 on PRODPC68 with BILLS